Clinical Trial

MPV as a Predictor for ACS in Patients With MASLD

Study acronym: MPV/ACS MASLD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Sohag University Hospital.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08-01 -> 2026-11-01 2026-05-07
minor Completion pushed: 2026-09-01 -> 2026-12-01 2026-05-07
Trial Details
NCT Number NCT07487571
Lead Sponsor Sohag University
Conditions Metabolic Dysfunction-Associated Steatotic Liver Disease, Acute Coronary Syndromes (ACS)
Enrollment 60 participants
Start Date 2026-05-05
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-06